Your browser doesn't support javascript.
loading
Definitive local therapy for T4 prostate cancer associated with improved local control and survival.
Andring, Lauren M; Abu-Gheida, Ibrahim; Bathala, Tharakeswara; Yoder, Alison K; Manzar, Gohar S; Maldonado, J Alberto; Frank, Steven J; Choi, Seungtaek; Nguyen, Quynh-Nhu; Hoffman, Karen; McGuire, Sean Eric; Mok, Henry; Aparicio, Ana; Chapin, Brian F; Tang, Chad.
Affiliation
  • Andring LM; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Abu-Gheida I; Department of Radiation Oncology, Burjeel Medical City, Abu Dhabi, United Arab Emirates.
  • Bathala T; Department of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Yoder AK; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Manzar GS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Maldonado JA; University of Texas Medical Branch at Galveston, Galveston, TX, USA.
  • Frank SJ; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Choi S; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Nguyen QN; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Hoffman K; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • McGuire SE; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Mok H; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Aparicio A; Department of Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Chapin BF; Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Tang C; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
BJU Int ; 132(3): 307-313, 2023 09.
Article in En | MEDLINE | ID: mdl-37057728

Full text: 1 Database: MEDLINE Main subject: Prostatic Neoplasms / Adenocarcinoma Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans / Male Language: En Year: 2023 Type: Article

Full text: 1 Database: MEDLINE Main subject: Prostatic Neoplasms / Adenocarcinoma Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans / Male Language: En Year: 2023 Type: Article